pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 396 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
(fluticasone propionate + salmeterol xinafoate)
Wixela Inhub ((fluticasone propionate + salmeterol xinafoate))
Asthma
Mylan Technologies Inc
0 catalysts
Marketed
(formoterol fumarate + glycopyrrolate)
Bevespi Aerosphere ((formoterol fumarate + glycopyrrolate))
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca Pharmaceuticals LP
0 catalysts
Marketed
(formoterol fumarate + mometasone furoate)
Dulera ((formoterol fumarate + mometasone furoate))
Asthma
Organon USA LLC
0 catalysts
← prev
page 4 of 14
next →
131
Pain89
Neurology1
Marketed
(guaifenesin + pseudoephedrine hydrochloride) ER
Mucinex D ((guaifenesin + pseudoephedrine hydrochloride))
Nasopharyngitis (Common Cold)
Reckitt Benckiser LLC
0 catalysts
Marketed
(homatropine methylbromide + hydrocodone bitartrate)
Hydrocodone Bitartrate + Homatropine Methylbromide ((homatropine methylbromide [INN] + hydrocodone bitartrate))
Cough
Abhai Inc
0 catalysts
Marketed
(hydrocodone bitartrate + pseudoephedrine hydrochloride)
Hydrocodone Bitartrate + Pseudoephedrine Hydrochloride ((hydrocodone bitartrate + pseudoephedrine hydrochloride))
Cough
Sciegen Pharmaceuticals Inc
0 catalysts
Marketed
(ibuprofen + phenylephrine hydrochloride)
Advil Congestion Relief ((ibuprofen + phenylephrine hydrochloride))
Nasopharyngitis (Common Cold)
$HLNHaleon plc
0 catalysts
Marketed
(ibuprofen + pseudoephedrine hydrochloride)
Ibuprofen + Pseudoephedrine Hydrochloride ((ibuprofen + pseudoephedrine hydrochloride))
Nasopharyngitis (Common Cold)
Strides Pharma Inc
0 catalysts
Marketed
(ivacaftor + tezacaftor) + ivacaftor
Symdeko ((ivacaftor + tezacaftor))
Cystic Fibrosis
$VERXVertex, Inc.
0 catalysts
Marketed
(loratadine + pseudoephedrine sulfate) ER
Loratadine + Pseudoephedrine Sulfate ((loratadine + pseudoephedrine sulfate))
Nasopharyngitis (Common Cold)
PL Developments Copiague LLC
0 catalysts
Marketed
(mometasone furoate + olopatadine hydrochloride)
Ryaltris ((mometasone furoate + olopatadine hydrochloride))
Seasonal Allergic Rhinitis
Hikma Pharmaceuticals USA Inc
0 catalysts
Marketed
(naproxen sodium + pseudoephedrine hydrochloride) ER
Naproxen Sodium + Pseudoephedrine Hydrochloride ((naproxen sodium + pseudoephedrine hydrochloride))
Acute Bacterial Sinusitis
L. Perrigo Company
0 catalysts
Marketed
(olodaterol hydrochloride + tiotropium bromide)
Stiolto Respimat ((olodaterol hydrochloride + tiotropium bromide))
Chronic Bronchitis
Boehringer Ingelheim Corp
0 catalysts
Marketed
(penicillin G benzathine + penicillin G procaine)
Bicillin C-R ((penicillin G benzathine + penicillin G procaine))
Bacteremia
$PFEPFIZER INC
0 catalysts
Marketed
(phenylephrine hydrochloride + promethazine)
Prometh VC Plain ((phenylephrine hydrochloride + promethazine [INN]))
Allergic Rhinitis
G&W Laboratories Inc
0 catalysts
Marketed
(piperacillin sodium + tazobactam sodium)
Piperacillin Sodium + Tazobactam Sodium ((piperacillin sodium + tazobactam sodium))
Community-Acquired Bacterial Pneumonia
Milla Pharmaceuticals Inc
0 catalysts
Marketed
(sulfamethoxazole + trimethoprim)
Sulfamethoxazole + Trimethoprim ((sulfamethoxazole + trimethoprim))
Enteritis
Vista Pharmaceuticals Inc
0 catalysts
Marketed
(umeclidinium bromide + vilanterol trifenatate)
Anoro Ellipta ((umeclidinium bromide + vilanterol trifenatate))
Chronic Bronchitis
GlaxoSmithKline LLC
0 catalysts
Preclinical
AB-2010
Idiopathic Pulmonary Fibrosis
Alveolus Bio Inc
0 catalysts
Preclinical
ABI-171
Idiopathic Pulmonary Fibrosis
Avanti Biosciences Inc
0 catalysts
Phase 3
AD-109
(atomoxetine [INN] + oxybutynin)
Obstructive Sleep Apnea
Apnimed Inc
0 catalysts
Preclinical
AKT-001
Acute Respiratory Distress Syndrome
Akttyva Therapeutics Inc
0 catalysts
Phase 1
ALX-1
Bronchiectasis
Parathyroid hormone/parathyroid hormone-related peptide receptor
Vast Therapeutics Inc
0 catalysts
Preclinical
AOARDS-069
Acute Respiratory Distress Syndrome
Aodh Lifesciences Pvt Ltd
0 catalysts
Phase 2
AON-D21
Community Acquired Pneumonia
Aptarion Biotech AG
0 catalysts
Phase 1
AONEUM-04
Pneumonia
Aodh Lifesciences Pvt Ltd
0 catalysts
Preclinical
AOXY-08
Hypoxia
Aodh Lifesciences Pvt Ltd
0 catalysts
Preclinical
AOXY-34
Hypoxia
Aodh Lifesciences Pvt Ltd
0 catalysts
Phase 2
APPA-02
Resistant Pseudomonas aeruginosa Infections
$ARMPArmata Pharmaceuticals, Inc.
0 catalysts
Preclinical
APT-101
Idiopathic Pulmonary Fibrosis
APIE Therapeutics Inc
0 catalysts